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Background: Approximately half of service users with schizophrenia or bipolar disorder do not fully follow treatment
recommendations. Studies of adherence have not adequately explored the frequency, consequences and meanings of
non-adherence behaviours from service users’ perspectives. This study contributes to a more fine-grained understanding
of treatment choices and the support service users require in order to maximise benefit from their medications.
Methods: This was a mixed-methods questionnaire study, employing quantitative and thematic qualitative analyses.
Thirty-five individuals with a diagnosis of, and receiving psycho-pharmaceutical treatment for, schizophrenia or bipolar
disorder answered online or telephone questions about whether, how, and why they deviated from their treatment
recommendations, and what support they currently and would like to receive.
Results: Over half of participants identified themselves as being non-adherent, however when asked in detail about
intentional and unintentional adherence, 77% reported deviating from treatment recommendations. Critically, 29% were
non-adherent and satisfied with being so. Service users’ satisfaction with their support was positively correlated with
satisfaction with their medication. Participants’ made treatment choices in order to live well. Both side-effects and
symptoms could be obstacles to adherence, but feeling well also impacted on participants’ treatment choices. Treatment
choices were often made in the context of living well day-to-day, and did not necessarily take into account longer-term
effects of non-adherence. Participants wanted more information about their medications, better emotional support
(including better access to psychological therapies) and stability in their relationships with health professionals.
Conclusions: This study suggests that non-adherence, both intentional and unintentional, is common amongst
individuals with diagnoses of schizophrenia and bipolar disorder, and that this often occurs without health professionals’
knowledge or support. Treatment choices reflect a desire to live well, but are often driven by short-term needs. Given
access to more information, and importantly to emotional support, service users could be helped to make treatment
choices that adequately reflect the long-term risks of non-adherence, as well as allowing them to live well day-to-day.
More research is required better to understand the meanings and complexities of service users’ treatment choices.
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It is well documented that, when it comes to utilising
treatments for psychotic illness, service user behaviour
does not always coincide with clinical prescription. While
there are variations in the way in which adherence is de-
fined and measured, and difficulties in obtaining an accur-
ate measurement [1-3], it is estimated that up to half, and* Correspondence: sgibson@sane.org.uk
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reproduction in any medium, provided the orpossibly more service users with schizophrenia or bipolar
disorder do not follow treatment recommendations[3-6].
Studies of adherence suggest further that there is a cor-
relation between non-adherence and poor outcomes for
the patient and his/her social group. Medication non-
adherence in particular is thought to raise the risk of
psychotic relapse by a factor of three to five [5], and in
schizophrenia is associated with rehospitalisation and poor
quality of life [4] with the risk of suicide nearly four times
higher in service users who are poorly adherent [7]. InLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Gibson et al. BMC Psychiatry 2013, 13:153 Page 2 of 12
http://www.biomedcentral.com/1471-244X/13/153bipolar disorder, there is a similar association with relapse,
hospital admission and suicide [8,9]. Even allowing for
some bi-directionality of the association between non-
adherence and poor outcomes [2,3], it is clear that there
are good reasons for wanting better to understand and
address treatment non-adherence.
While there are a number of specifically targeted inter-
ventions aimed at improving adherence, referred to as
‘adherence therapy’ or sometimes ‘compliance therapy’
the UK National Institute for Health and Clinical Excel-
lence (NICE) [10,11] guidelines for the treatment of
schizophrenia and bipolar disorder advise against using
adherence therapy. This may be because of the absence
of evidence for their effectiveness: studies of adherence
therapy for schizophrenia have shown moderate or no
effect on medication adherence, and none on symptom
reduction or quality of life [12]. Similarly in bipolar dis-
order, although recommendations have been made to
target knowledge and attitudes about medication and
the issue of adherence itself in therapy, Gray et al [13]
found that the evidence for the efficacy of such interven-
tions is inconclusive. Berk et al [2] found some evidence
of success in psychosocial interventions directly targeting
adherence for people diagnosed with bipolar disorder, al-
though they acknowledge that the small number of studies
means that there is a lack of a sufficient evidence base.
More research has been carried out into interventions
where adherence is a secondary outcome. Here the evi-
dence suggests that while some interventions can improve
adherence and/or outcomes for people with bipolar dis-
order, there are a number of variables involved [2].
What service users do is one such variable. Thus ra-
ther than treating non-adherence as a conglomerate
concept, it is useful to consider the different ways in
which service users diverge from treatment recommen-
dations. For example a service user might increase or
decrease the amount of medication that they take, and
do so either for a short or long period of time. They
might change the time at which they take their medica-
tion, continue to follow some recommended courses of
treatment while not adhering to others, or they might
stop taking medication altogether. Adherence behaviour
is also something that fluctuates over time [14], and may
be intentional or unintentional [2,9]. While these factors
impact on the outcomes of non-adherence and success
of interventions there is a further, perhaps related di-
mension to consider. That is, what informs and influ-
ences service users’ decision-making and behaviour with
regard to adherence and non-adherence?
While understanding both what service users do and
how they make and evaluate decisions about following
treatment recommendations may be requisite for devel-
oping and targeting interventions that are successful in
improving adherence [2,9], added to this is a concern toensure that treatment decisions are based on a collabora-
tive therapeutic alliance that takes into account the per-
spective of the service user. Thus it is noted that there has
been a move away from the language of ‘compliance’ to
that of ‘adherence’, reflecting the role of the service user
within the therapeutic relationship in discussing and
agreeing a course of treatment, and in deciding to follow
the recommendations [2,15].
Taking this further, the recovery model looks beyond
treating symptoms and preventing relapse in severe and
enduring mental illness to a more holistic view that in-
cludes establishing or re-establishing an integrated sense
of self as competent and self-directing [16,17]. Here the
need for a collaborative approach to treatment based on
an understanding of the first-hand experience of the ser-
vice user is twofold: first in determining what recovery
means to that person, and second in facilitating a sense
of agency.
This paper reports on a study investigating first person
accounts of treatment adherence decisions and behaviours
among service users with a diagnosis of schizophrenia or
bipolar disorder, and their perspectives on available and
desired support to maximise benefit from their treatment.
By eliciting some of the more fine-grained aspects of ser-
vice users’ treatment choices, the study contributes to an
approach that takes seriously the role of the service user
in successfully managing and living with a severe and en-
during mental illness.
Method
Participants
Forty-one people living in England with both a diagnosis
of and receiving treatment for either schizophrenia or
bipolar disorder were recruited. Thirty-five reported re-
ceiving psycho-pharmaceutical treatment and their re-
sponses are reported in this paper (N = 35). Participants
were recruited via the SANE website, and through publi-
city in SANE communications, including social media.
The majority of participants defined themselves as White
British (n = 23), with 1 reporting their ethnicity as White
English, 1 as Asian Indian, 1 as Asian Pakistani, 1 as
Welsh, and eight did not respond. Ten reported having a
diagnosis of schizophrenia and 24 a diagnosis of bipolar
disorder. One participant reported having a diagnosis of
both schizophrenia and bipolar disorder. Twenty-five were
being treated by a psychiatrist, 17 were being treated by a
primary care physician, 1 was being treated as an inpatient,
and 14 as outpatients. Four were also receiving individual
therapy, 1was in group therapy, and 1 was receiving both.
Ethics
The study received ethical approval from the North
London Research Ethics Committee 2 (REC reference
number: 10/H0724/37). Participants gave their informed
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ate box) that they had read and understood the Participant
Information Sheet. It was not possible for participants to
progress with the online study until they had given their
consent. Participants taking part by telephone completed
the same procedure verbally with the researcher, having
been sent a copy of the Participant Information Sheet in
advance. Participants were informed that their responses
may be published, but their anonymity would be protected.
Design and measures
This was a mixed-methods questionnaire study. The
questionnaire was delivered online or via telephone, and
aimed to gather information about how often, in what
way, and why service users deviate from their treatment
recommendations. Up to 42 multiple choice and open-
ended questions asked service users to give their own
reasons related to a variety of prescribed possible ways
of regulating their medication [see Additional file 1].
The questionnaire asked participants about both psycho-
pharmaceutical and non-medical treatments; the results
that we report on here are derived from the questions
concerning the former. Intentional non-adherence and
unintentional non-adherence were both explored, and
service users were also asked about their expectations of
what would happen, and what actually happened when
they deviated from treatment recommendations. Partici-
pants were also asked about the extent to which they
discuss their treatment non-adherence with their health
care professional, and what informed those decisions. Fi-
nally, they were asked about available and desired sup-
port in relation to their diagnoses.
Adherence was measured by self-report [14]. Service
users were asked whether they followed treatment recom-
mendations exactly, or did something different. They were
also asked to describe their intentional and/or unintentional
non-adherence and to estimate the frequency of each.
Data analysis
Quantitative data was explored primarily with descrip-
tive statistics. Chi-square analyses and non-parametric
correlations were undertaken where feasible and useful
(all with a threshold of p < 0.05).
Qualitative data was explored using a thematic analysis
following the guidelines of Braun & Clarke [18]. Data
was initially coded inductively, before codes were clus-
tered into themes and subthemes. Themes were devel-
oped on the basis of their prevalence across the data-set,
and with reference to potential theoretical interests.
Qualitative analysis was initially carried out by one au-
thor, then, to increase validity, themes were independ-
ently checked against the data by the other researchers.
Any differences of opinion were discussed and resolved
by all authors. There were no instances of disagreementon themes which were not resolved satisfactorily. Partici-
pant quotations were chosen to best illustrate the theme
under discussion.
Results
Quantitative
Service users were asked how closely they followed their
treatment recommendations, and 46% (n = 16) reported
following recommendations exactly. However, when asked
to describe the different ways in which they did something
different to recommendations, while 54% (n = 19) reported
intentional non-adherence, 71% (n = 25) reported uninten-
tional non-adherence, with a total of 77% (n = 27) doing
something different to recommendations. That is, half of
those (n = 8) who reported following treatment recom-
mendations exactly then went on to describe occasions on
which they were unintentionally non-adherent. Of those
who reported intentional non-adherence, roughly half
were intentionally non-adherent at least twice a month;
likewise, of those who were unintentionally non-adherent,
roughly half were unintentionally non-adherent at least
twice a month (Table 1).
Service users reported their expectations and the out-
comes of intentionally doing something different to
treatment recommendations. On 55% of those occasions
when service users had a positive expectation (including
expectations of no change), they also experienced a posi-
tive outcome (including outcomes of no change). On
45% of those occasions when service users expected a
positive outcome (including expectations of no change),
they experienced a negative outcome. On all of those oc-
casions when service users had a negative expectation,
they then experienced a negative outcome. Notably, while
on the majority of occasions of intentional non-adherence,
service users had positive expectations, there were still
some occasions (n = 5) on which service users chose not
to follow recommendations despite expecting negative
consequences (Table 2).
Thirty-four percent (n = 12) of service users reported
that they would like to change the way they followed their
treatment recommendations, with 20% (n = 7) wanting to
follow them more closely and 14% (n = 5) less closely.
Sixty-six percent (n = 23) did not want to change the way
they followed recommendations. Of those who did not
want to change the way they followed their recommenda-
tions, only 57% (n = 13) reported that they followed rec-
ommendations exactly. This means that nearly a third of
service users (29%, n = 10) did not take medication as
recommended and were happy with their level of adher-
ence (Table 3).
Service users were asked to rate their satisfaction with
their current medication on a scale of 1 (not at all satis-
fied) to 5 (very satisfied) (Figure 1). They were also asked
to rate their satisfaction with their current support
Table 1 What service users do: self-reported service user
behaviours
Self-reported service user behaviour Service users
(no./total (%))
Service users who reported following
recommendations exactly
16/35 (46)
Service users who described intentionally
and/or unintentionally doing something
different to recommendations
27/35 (77)
Service users who described intentionally
doing something different to recommendations
19/35 (54)
Of these
• 2 or more times a month 9/19 (47)
• Intentionally taking less medication 12/19 (63)
• Intentionally taking more medication 12/19 (63)
Service users who described unintentionally
doing something contrary to recommendations
25/35 (71)
Of these
• 2 or more times a month 12/25 (48)
• Forgot to take medication 17/25 (68)
• Symptoms prevented taking medication 12/25 (48)
• Unable to motivate self to take medication 12/25 (48)
• Practical reasons 9/25 (36)
• Unsure about recommendations 5/25 (20)
• Lost prescription 1/25 (4)
Table 2 Service user expectations and outcomes: self-
reported service user behaviours
Self-reported service
user behaviour
Occasions of intentional
non-adherence (no. / total (%))
Occasions on which service users’
expectation of a positive outcome
was followed by an outcome of
the same valence
18/33 (55)
Occasions on which service users’
expectation of a negative outcome
was followed by an outcome of the
same valence
5/5 (100)
Occasions on which service users’
expectation of a positive outcome
was followed by an outcome of
negative valence
15/33 (45)
Occasions on which service users
correctly predicted positive or
negative valence of the outcome
of doing something contrary
to recommendations.
23/38 (61)
Gibson et al. BMC Psychiatry 2013, 13:153 Page 4 of 12
http://www.biomedcentral.com/1471-244X/13/153(Figure 2). There was a significant positive correlation
between satisfaction with support and satisfaction with
medication received (rS = 0.43, N = 35, p = 0.01).Qualitative: Thematic analysis
Three main themes were identified: ‘Living well for self and
others’; ‘Obstacles to adherence’; ‘Therapeutic support’.Living well for self and others
Subthemes: ‘Staying well and avoiding negative conse-
quences’; ‘Managing side-effects and symptoms’
The reasons service users gave for either following or
intentionally not following treatment recommendations
can be analysed under the theme ‘Living well for self
and others’. That is, service-users made decisions about
their treatment recommendations in order to live as well
as possible with the symptoms of their diagnosis and the
side-effects of medications, with decision-making taking
place in response to the demands of everyday living.
The reasons given by service users for always or some-
times following recommendations formed the subtheme
‘Staying well and avoiding negative consequences’. Treat-
ment recommendations were adhered to insofar as
medication was seen as necessary to stay well and live asgood a life as possible or insofar as it was necessary to
avoid negative consequences
“To stay in one piece, stay balanced” (P13)
“In order to get the very best out of life and remain
safe” (P1)
“Meds keep my head just above water, failing taking
them…I and people around me pay the price” (P41)
“Scared of being sectioned and I dislike some of the
Schizophrenia symptoms” (P35)
This subtheme was further supported by service users’
reasons for satisfaction with their current medication
“As long as I’m on medication I haven’t been ill” (P11)
“I started to get my life back and have some degree of
normality” (P39)
Conversely, dissatisfaction with current medication
appeared to reflect the ways in which medication failed
to support ‘living well’, for example problems with side-
effects, lack of efficacy in controlling symptoms or the
burdens associated with following a treatment course:
“long term health effects and side effects. It’s toxic” (P28)
“I was once very active and went to the gym 4 times a
week, now I have become lethargic and fatigued from
my medication” (P23)
Table 3 Service user desire to change/not change
treatment behaviour
Service user self-report Service users
(no./total (%))
Did want to change the way they
followed recommendations
12/35 (34)
• Follow more closely 7/35 (20)
• Follow less closely 5/35 (14)
Did not want to change the way they
followed recommendations
23/35 (66)
Of these
• Doing something different to recommendations 10/23 (43)
Not following recommendations and did not
want to change their level of adherence
10/35 (29)
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disturbance” (P1)
“… monthly or fortnightly my mood drops and I have
a severe depression lasting about a week” (P41)
“I am really fed up with … having to have a blood test
every four weeks” (P35)
“I just wish I didn’t need to take so much medication”
(P19)
The reasons given by service users for intentionally doing
something different to their treatment recommendations
informed the subtheme ‘Managing side-effects and symp-
toms’. Here there was still a concern with living well, and
changes were made in order to manage side-effects and
symptoms in a way that enabled service users to live with
the difficulties associated with their diagnosis and medica-
tion. Those who took more medication tended to frame
their reasons in terms of managing symptoms; those
who took less mediation tended to frame their reasons
in terms of managing side-effects, although some ser-
vice users reported taking less medication because
they felt well
“I started feeling depressed and wanted to increase my
dose so I slept through the day” (P18)
“Intensity of voices made it hard to cope” (P3)
“Didn’t like the sedative side effects” (P15)
“I had a meeting at work the next day so skipped my
evening dose” (P9)
“I had been coping well for a significant period of
time” (P33)“I feel okay on less and see no reason to take more” (P39)
Changing the time of medication tended to be associ-
ated with managing sleep patterns and tiredness
“I was working nights and needed to feel alert during
the night” (P9)
“Took antidepressants once a day rather than twice
a day, to have more energy during the day” (P3)
Obstacles to adherence
Subthemes: ‘Feeling well enough’; ‘Contending with side-
effects and symptoms’
Service users were asked to select from a list of op-
tions that best described the reasons for their uninten-
tional non-adherence (Table 1). Analysis of the service
users’ accounts of their unintentional non-adherence
suggested the theme ‘Obstacles to adherence’ with 2
subthemes, ‘Feeling well enough’ and ‘Contending with
side-effects and symptoms’.
Thus although 17 service users reported that they had
forgotten to take medication (Table 1), within this group
the experiences described differed notably. For some, for-
getting appeared to be a function of ‘Feeling well enough’,
that is, of a remission of symptoms and/or being busy or
generally engaged with everyday life
“Just forgot too busy at work” (P15)
“Somehow I forgot to take the medication, maybe
because I was feeling well” (P25)
For others ‘forgetting’ was part of the experience of
“Contending with side-effects and symptoms”
“last night I forgot to take my lithium because I was
too tired and didn’t want to feel sick” (P23)
“Last week, was awake for three days did not take any
medicine during this period” (P14)
This also incorporated aspects of loss of motivation:
“too mentally and physically tired to get out of bed
and fetch medication/water” (P27)
“I didn't feel like doing anything and taking
medication was one of those things” (P37)
as well as the experience of symptoms directly
impacting on adherence, including delusional thoughts
or fears about medication, hopelessness, hallucinations,
Figure 2 Service user satisfaction with support.
Figure 1 Service user satisfaction with medication.
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on symptoms
“I wanted to know what I really thought and I believed
that the medication was controlling my thoughts - so it
had to be stopped” (P35)
“Too low felt there was no point as was going to kill
myself anyway” (P15)
“I am hearing bad voices and they sometimes tell me
that the medication is poison” (P7)
“I was high as a kite” (P4)
“Thought I might feel better if dose missed
occasionally” (P16)
Further, where service users reported practical diffi-
culties these might sometimes be understood as com-
bining with side-effects or symptoms with a resulting
increased impact
“I was stuck in a flat with little energy after being on
two lots of medication sleeping 16 hours or more with
no transport” (P24)
One shared element of the two themes presented so
far is the way in which decision-making and behaviour
tends to be in response to the day-to-day challenges and
demands of living with a severe and enduring mental
illness, rather than on longer term considerations. This
will be discussed below.Therapeutic support
Subthemes: ‘Enabling and disabling communication’;
‘Supporting the person’
The role of the therapeutic relationship featured in
service user accounts in a number of ways, analysed under
the theme ‘Therapeutic support’ with the subthemes
‘Enabling and disabling communication’ and ‘Supporting
the person’.
Good experiences of communication were enabling in
the sense that the service users felt supported and better
able to manage their illness. However, in other cases
communication was experienced as impaired and
impairing, such that service users felt unable to com-
municate, or where attempts to communicate were met
with a less than satisfactory response. Also informing
this was the desire for more and better information to
help support treatment choices.
Hence service users were asked whether they
discussed the times when they had not followedtreatment recommendations with their doctor. Some of
the reasons for not discussing non-adherence related to
concerns about the consequences, accessibility of health
care professionals, or to the service user’s own state
of mind
“in fear he may take me off the haloperidol” (P7)
“frightened of being sectioned” (P27)
“I don’t see the doctor for another 6 months” (P3)
“I didn’t want to interact with anyone” (P18)
“too ashamed” (P26)
In other cases service users described a relationship in
which they felt trusted to make their own decisions, or
appeared to trust themselves to make the decision
“When the ground rules were established with my
recent GP, it was discussed that I could increase or
decrease (by a small amount) my medication as and
when required” (P33)
“the medication dosage works and I see no reason to
change as I am not taking too much” (P8)
Where service users had discussed their non-
adherence, this had in a number of cases resulted in a
positive outcome
“my psychiatrist is going to review my anti d
[epressant]” (P7)
“Slow release anti-depressant prescribed. So I only
need to take it once a day” (P3)
However, in other cases there were blocks to commu-
nication, or communication resulted in a negative
outcome
“I told the Dr the symptoms but wasn't honest about
what medication I was taking less of” (P18)
“They were not willing to listen to the prescription
mess up that had occurred and just said I had decided
to stop taking meds myself” (P37)
“I was ‘bullied’ into taking a different medication”
(P35)
The desire for more and better information to help
support treatment choices included wanting to be
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about the long term effects of medication, and information
about the effects of taking medication while pregnant
“Independent, unbiased information about my
medication and other possible treatments” (P3)
“Information about long term consequences of the
medications” (P10)
“Access to studies about my medication and
pregnancy” (P9)
However, although making informed choices was per-
ceived as important and providing information part of
the role of the healthcare professional, there was also a
clear need for emotional support, including stability of
care, which informed the subtheme ‘Supporting the
person’.
There were a substantial number of positive experi-
ences of support from healthcare providers
“My psychiatrist is fantastic with email access and I
have her mobile number” (P15)
“I have had excellent support from my GP and know
that I could call him anytime and he would help in
any way he could” (P33)
“I have access to different types of support when I need
it and also touch base with professionals to check all is
ok. I know I can ring my care co-ordinator whenever I
need to” (P37)
Others described mixed experiences or a need for im-
proved therapeutic support
“CPN very supportive. Psychiatrist being changed all
the time” (P14)
“I get good support from my psychiatrist and my
CPN but my GP is not approachable or involved”
(P35)
“would like a CPN again (I used to have one) or a
support worker/someone to talk to” (P27)
“I am not listened to regarding the side effects of my
medication and no peer group support has been
offered” (P9)
“I don't get any support unless I ask for it, and
sometimes I am so cross I don't feel I can in what is
considered an appropriate way, The doctor does notknow me well, I had to change due to moving and they
don't try to understand” (P2)
Here, being listened to and understood appears to be
an important part of feeling supported, and a number of
service users pointed to the lack of talking therapies. In
addition, when asked what additional support they would
like, participants expressed a desire for more talking
therapies
“Do have some support but would prefer regular
counselling and transport to it” (P24)
“I get medical attention I think I need except talking
therapies” (P13)
“I think being offered some type of group or individual
therapy would be really beneficial” (P18)
“More talking therapy and counselling to give me
peace of mind” (P1)
Discussion
What do service users do and why?
Previous studies suggest that around 50% of service users
are non-adherent, although as it was noted above, there are
competing definitions and different measurements of ad-
herence, as well as difficulties in obtaining an accurate
measurement [3,5]. This study reflects these findings, with
46% of service users reporting that they follow treatment
recommendations exactly. However, of these, half then de-
scribed occasions on which they had unintentionally done
something different to recommendations. That is, in this
study, service users reported that they followed treatment
recommendations exactly unless they considered that they
were intentionally doing something different to their rec-
ommendations. Of those who had intentionally done some-
thing different to recommendations, roughly half reported
doing so twice a month or more. Of those who had unin-
tentionally done something different, roughly one third
reported doing so twice a month or more (Table 1).
The accounts that service users gave of their reasons for
adhering and deliberately not adhering to treatment rec-
ommendations informed the theme ‘Living well for self
and others’. Again in line with previous studies, the rea-
sons given for following recommendations were perceived
efficacy of medication in controlling symptoms and enab-
ling wellness, and a desire to avoid negative outcomes, in-
cluding relapse and negative social consequences [5,9,15].
This was further reflected in the reasons given for satisfac-
tion with medication.
Service users’ accounts of their reasons for intentionally
doing something different to recommendations informed
the subtheme ‘Managing side-effects and symptoms’, while
Gibson et al. BMC Psychiatry 2013, 13:153 Page 9 of 12
http://www.biomedcentral.com/1471-244X/13/153in cases of unintentional non-adherence, some service
users appeared to be ‘Contending with side-effects and
symptoms’. Participants described the impact of psychotic,
manic and depressive symptoms on adherence. While
non-adherence is known to be correlated with the manic
phase in bipolar disorder, there is a lack of understanding
of the relationship between depressive symptoms and
non-adherence [2]. In this study depressive symptoms
were given as reasons both for taking more and taking
less medication, and for intentional and unintentional
non-adherence.
That the same symptoms can impact on both intentional
and unintentional non-adherence might support Basco &
Smith’s [14] claim that there is not always a clear distinction
between intentional and unintentional non-adherence.
However, it appears that there is an important difference in
the way in which symptoms are experienced as reasons for
non-adherence, which we have analysed by contrasting
‘managing symptoms’ with ‘contending with symptoms’.
Thus for example, for one service user depressive symp-
toms informed the decision to take more medication when
they were “feeling very low and recognize[d] the signs of
spiraling into a depression” (P33), while for another it
prevented their following recommendations as they “didn't
feel like doing anything and taking medication was one of
those things” (P37). Likewise, one service use took more
medication because “intensity of voices made it hard to
cope” (P3) while for another “voices instructed me not to
take the tablets” (P14). This points to the complexity of ser-
vice users’ lived experience of managing their medication
and the symptoms of their illness.
An absence of symptoms also impacted on whether ser-
vice users’ followed treatment recommendations. That is,
in some cases, ‘feeling well enough’ appeared to present an
obstacle to adherence. The relevance for adherence of
accepting a diagnosis and coming to terms with the impli-
cations of managing a long-term severe and enduring
mental illness has been recognised [15]. One participant’s
description of having forgotten to take their medication
seems to acknowledge explicitly that this is a factor in de-
termining treatment behaviour, saying “I missed a few days
because (a) I was extremely busy and distracted and (b)
subconsciously I didn't want to take it because I occasion-
ally become very resentful of the fact that I have to take
medication every day” (P33).
In their review, Clatworthy et al [9] found that con-
cerns about side-effects were associated with non-
adherence in bipolar disorder and DiBoventura et al [19]
found a significant association between self-reported side
effects and non-adherence in people with schizophrenia,
in particular extra pyramidal symptoms and agitation,
and metabolic side effects such as weight gain. In this
study intentional non-adherence was associated with a
wish to avoid side effects such as tiredness and feelingsedated; physical side effects such as weight gain and
agitation were among the main reasons given by those
participants who reported a low level of satisfaction with
their medication.
One question is whether the impact of side-effects on
service users’ treatment choices represents a reasoned
weighing of relevant considerations or whether it should
instead be construed as an absence of adequately informed
decision-making [3,14]. Some appear to take it as evidence
of the latter. For example, Pope & Scott [6] distinguish be-
tween side-effects and fear of side-effects informing
decision-making and Basco & Smith [14] suggest that a
memory of unpleasant side-effects might inform an
affective rather than reasoned response. In this study,
where participants described intentional non-adherence,
they appeared to refer to decision-making informed by
current rather than remembered or conjectured side-
effects suggesting that the undoubtedly real side-effects in-
formed rather than skewed service users’ decisions. This is
discussed further below in the context of the time-scale
for service user decision-making.
First, however, we consider further the context for ser-
vice user behaviour and decision-making.Understanding service user treatment choices
The idea of a collaborative approach to treating severe and
enduring mental illness, and the concept of recovery,
point to a need to understand not only the nature of and
reasons for treatment adherence and non-adherence, but
also the broader context in which service users’ decision-
making and behaviour takes place.
Critically, this study found that nearly one-third of ser-
vice users with bipolar disorder or schizophrenia were both
non-adherent and satisfied with being so. Thus while the
literature points to the negative impact of non-adherence,
at least some participants appeared to have found a way of
adjusting their treatment that they didn’t want to change.
While it is clear that there is an association between non-
adherence and poor outcomes, this aspect of service user
experience requires further investigation. For example, it
has been pointed out that there may be a bi-directional re-
lationship between non-adherence and relapse with the
possibility that adherence decreases when the service user
is becoming unwell, as well as non-adherence leading to
relapse in some cases [2]. If it is the case that the causal re-
lationship between non-adherence and poor outcomes is
not straightforward, then one explanation for service user
satisfaction with non-adherence might be that, on some
occasions at least, non-adherence does not result in a
poor outcome.
Alternatively, this aspect of service user experience might
be explained as a function of another finding from this
study. That is, that service user treatment choices occur on
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ary living, for example taking less medication in order to
stay alert, or taking more in order to sleep through depres-
sive feelings. That is, it appeared that decisions not to
follow treatment recommendations were made in order to
live well by balancing side effects and symptoms on a day-
by-day basis, rather than to support long-term goals such
as preventing relapse.
Further, where it was found that service users’ choices
about medication self-regulation were in most although
not all cases informed by realistic expectations about the
positive or negative valence of the outcome, expectations
and outcomes of non-adherence were again focused on
the short-term rather than the long-term. Thus while
this suggests that many service users self-regulated their
medication in response to a relatively realistic weighing
up of the short-term, or day-to-day costs and/or benefits
of non-adherence, it leaves open the question of whether
these were taken to outweigh longer-term considerations
such as the risk of relapse, or whether longer term con-
siderations were not taken into account (although it is
worth noting that where participants expressed a desire
for more and better information, this included informa-
tion about the long-term effects of taking medication).
Again, the focus on day-to-day decision-making can
be analysed in different ways. One possibility is to inter-
pret service users’ reasoning as flawed, insofar as the
longer term risks of non-adherence are not given suffi-
cient weight against the expected short term benefits.
Another, perhaps more appropriate understanding at-
tends to the significance of the day-to-day experience of
managing a severe and enduring mental illness, where
balancing side-effects and symptoms in order to respond
to the demands of everyday living is as important as lon-
ger term goals such as preventing relapse. Thus Basco &
Smith [14] suggest that understanding non-adherence
requires attention to the daily obstacles and decision-
making that informs behaviour; extending this point
further it might be argued that understanding what re-
covery means for a service user requires an understand-
ing of the everyday experiences that are the building
blocks of a life well lived. This is not to say that encour-
aging service users to take long-term as well as short-
term outcomes into account is misguided, but rather
that what is required is an expanded perspective on the
context for service user treatment choices in order to
support those choices and the desire to live well.
Supporting service user treatment choices
One implication of the daily focus of service users’ treat-
ment choices is a conflict of time frame between service
user decision-making and access to clinical support and ex-
pertise. There are of course practical limits to the availabil-
ity of direct support from health care professionals, andwhere the need for ‘Therapeutic support’ consists in a de-
sire for more and better information, there are a number of
ways in which this might be provided, for example through
an online resource such as the ‘Choice and Medication’
website (http://www.choiceandmedication.org/cms/). How-
ever, it is clear that the need for support from health care
professionals extends beyond providing advice and infor-
mation to ‘Supporting the person’
The therapeutic relationship has been seen by some as an
important predictor of adherence [2,15]. However, this
study suggests that while the therapeutic relationship is im-
portant to service users, the quality of the alliance is a fac-
tor in their satisfaction with support (which is in turn
correlated with satisfaction with medication), rather than
for treatment adherence as such. This can be compared
with a recent study of the correlation between clinician and
patient ratings of the therapeutic relationship and treatment
adherence in schizophrenia [4]. While both clinician and
patient ratings of the therapeutic relationship were linked
with adherence (i.e. a higher rating correlated with better
adherence), there was a stronger correlation between clin-
ician ratings and adherence than between patient ratings
and adherence. As the authors of the report suggest, one
explanation for this is that clinicians might take a more
positive view of the therapeutic relationship in part because
a patient is adherent; the patient on the other hand might
well base their assessment on broader criteria.
In the light of this, it is also interesting to note that while
fewer than 20% of service users in our study received non-
medical treatment, this was highlighted as one of desired
areas of additional support. The UK All Party Parliamen-
tary Group on Mental Health [20] recently identified lack
of access to psychological therapies for people with schizo-
phrenia as one obstacle to implementing NICE guidelines,
and even if the evidence supporting the relationship be-
tween psychological therapies and adherence is equivocal,
there is evidence that psychotherapy can improve overall
outcomes for people with bipolar disorder and schizophre-
nia [3,16]. Further, Lysaker & Roe [21] argue for the role
of psychotherapy in a broader concept of recovery that
looks beyond the control of symptoms to “the recapture
of a coherent personal narrative and/or of metacognitive
capacity”. We suggest that psychotherapy that focuses
on building a coherent sense of self as a person with both
future goals and immediate needs would also aid in
helping service users to integrate short-term and long-
term decision-making with regard to their treatment
recommendations.Limitations
Limited resources meant that a relatively small number of
participants were recruited to the study, such that statis-
tical analyses lacked power. For example, significant
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such as satisfaction with medication and satisfaction with
support were not found. Likewise no significant associa-
tions were found between service users’ diagnoses and
reasons for non-adherence. A larger study would allow
further statistical analysis and further qualitative explor-
ation of the experiences of people with different diagnoses
and different levels and types of adherence and
non-adherence.
As this study focused on service users’ perspectives
and the ways in which they described and understood
their own behaviour, adherence was measured by self-
report; that is participants were asked whether they
followed treatment recommendations exactly, and if they
did something different, to estimate how often. Use of a
validated adherence measure might have given a more
accurate result. However, since the aim was not primar-
ily to measure adherence but to understand the context
for service user treatment choices, it was considered that
the disadvantages of asking participants to complete
an adherence measure, particularly with regard to en-
couraging them to complete the questionnaire, would
outweigh the advantages.Conclusion
Whilst medication non-adherence carries serious risks
for service users, more than half of service users
taking medication for either schizophrenia or bipolar
disorder do something different to their treatment
recommendations.
This study suggests that the reality for people with a
diagnosis of schizophrenia or bipolar disorder is that man-
aging their illness and living well requires balancing side
effects and symptoms, and that this in many cases means
at least occasionally departing from treatment recommen-
dations. Where service users were intentionally and/or un-
intentionally non-adherent, this was usually in response to
the day-by-day challenges of ordinary living, standing in
stark contrast to the time frame according to which clin-
ical interactions tend to take place. While many service
users reported good experiences of clinical support, there
was a perceived need for more extensive provision in this
respect, including greater access to talking therapies.
Future research should focus on developing interven-
tions to help service users to understand and manage
the risks, and to offer them non-judgemental informa-
tion, support and advice.Additional file
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